Literature DB >> 7272899

Kinetic and morphologic alterations in the colon of a patient with multiple polyposis.

E E Deschner, R F Raicht.   

Abstract

The histologic and proliferative characteristics of 16 colonic biopsies taken from an operative specimen of a 38-year-old female patient with multiple polyposis are presented. Kinetic measurements are based on 3HTdR incorporation accomplished in vitro, using both single and double labelling techniques. Epithelial cells in adenomatous tissue were more actively engaged in DNA synthesis than those normal-appearing mucosa (L.I.13.0 +/- 6.9 versus 9.3 +/- 1.6); however, because of extreme variability between biopsies, the difference was not significant. No difference in S phase duration was found, but a faster turnover time (Tg) than that in the normal appearing colonic mucosa was estimated (Tg 52.6 hours versus 74.2 hours). Only two of ten biopsies containing normal-appearing mucosa had a completely normal incorporation pattern with proliferative cells located only in the lower two thirds of crypts. Eight biopsies showed extension of the proliferative compartment to the luminal surface. One of these eight also expressed an additional proliferative defect, namely, a shift of the major zone of DNA synthesis to the middle and upper regions of the crypts. This specimen had been located adjacent to an area of microscopic adenoma. Subpopulations of labelled epithelial cells showing transition from normal to hyperplastic or to adenomatous appearance were in the otherwise normal-appearing crypts. The majority of labelled hyperplastic-appearing cells occupied the lower thirds of the crypts, whereas 68% of labelled adenomatous-appearing cells were located in the middle and upper zones of the glands. Based on these observations, the development of an adenoma is believed forecast by the redistribution of the proliferative compartment toward the surface. A further stage in tumorogenesis before the appearance of a focus of neoplasia is the emergence of actively proliferating cells transforming to a more adenomatous appearance primarily in that same location, that is, the middle and upper third of the colonic crypts.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7272899     DOI: 10.1002/1097-0142(19810515)47:10<2440::aid-cncr2820471022>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

Review 2.  Familial colonic cancer syndromes.

Authors: 
Journal:  West J Med       Date:  1983-09

3.  Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients.

Authors:  P Domizio; I C Talbot; A D Spigelman; C B Williams; R K Phillips
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

4.  The role of bile acids in colonic carcinogenesis.

Authors:  N Breuer; H Goebell
Journal:  Klin Wochenschr       Date:  1985-02-04

5.  Human secretory immunoglobulin A may contribute to biofilm formation in the gut.

Authors:  R Randal Bollinger; Mary Lou Everett; Daniel Palestrant; Stephanie D Love; Shu S Lin; William Parker
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

6.  In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis.

Authors:  J Sträter; K Koretz; A R Günthert; P Möller
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

7.  Genetic transmission of colorectal cancer: exploratory data analysis from a population based registry.

Authors:  M Ponz de Leon; C Scapoli; G Zanghieri; R Sassatelli; C Sacchetti; I Barrai
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

Review 8.  Do all colorectal carcinomas arise in preexisting adenomas?

Authors:  J R Jass
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.